Sibylla Biotech

Series A

Verona, ItalyOct 2022

Sibylla Biotech raised €23M in a Series A round in Oct 2022. The company is based in Verona, Italy. Investors in the round: 3B Future Health Fund, CDP Venture Capital, Claris Ventures and 6 others. Data as of 4 Nov 2026.

← Sibylla Biotech

Amount raised

€23M

€23,000,000

Native amount

23,000,000 EUR

Stage

Series A

series a

Investors

Provenance & confidence

High confidence

Amount

Reported in EUR — no conversion. €23M

High confidence

Source

finsmes.com · established

High confidence

Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.

Investors in this round

9 named

3B Future Health Fund CDP Venture Capital Claris Ventures Evolution Ventures Indaco Venture Partners Seroba Life Sciences V-Bio Ventures Vertis SGR VI Partners

Date

Oct 2022

Round type

series a

Amount (EUR)

€23M

Other rounds

same company

This is the company's only recorded round.

Sibylla Biotech

Provenance & confidence

Investors in this round

Other rounds

Related news